Table 1.
Previously reported cases of esophageal or esophagogastric MANEC
| Case | Age | Sex | Location | Treatment | Tumor size (cm) | Tumor depth | LN metastasis | Adjuvant chemotherapy | Recurrence | Prognosis | Author, year |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 64 | Male | Ut | Surgery | 1.7 | T1 | N0 | None | None | Alive (16 months) | Kitajima, 2013 |
| 2 | 63 | Male | EGJ | Surgery | 9.7 | T3 | N2 | NAC (CDDP + CPT-11), adjuvant (S-1 + CDDP) | None | Alive (24 months) | Nakai, 2013 |
| 3 | 68 | Male | EGJ | ESD | ND | T1 | ND | ND | ND | ND | Veits, 2013 |
| 4 | 68 | Male | Lt | Surgery | 9.5 | T4 | Positive | ND | ND | ND | Kadhim, 2016 |
| 5 | 57 | Male | EGJ | Surgery | ND | T3 | N3 | Chemoradiation (details ND) | None | Alive (8 months) | Juanmartinena, 2017 |
| 6 | 64 | Female | Mt | Surgery | 4.0 | T2 | N1 | Platinum and VP-16 | Supraclavicular lymph nodes and liver (4 months) | Dead (8 months) | Yuan, 2017 |
| 7 | 62 | Male | Mt | Surgery | 6.0 | T2 | N2 | Platinum and VP-16 | Pleural effusion (2 months) | Dead (19 months) | Yuan, 2017 |
| Our case | 70 | Male | EGJ | Surgery | 2.5 | T1 | N0 | None | None | Alive (4 months) |
Mt middle esophagus, EGJ esophagogastric junction, Lt lower esophagus, Ut upper esophagus, ESD endoscopic submucosal dissection, NAC neoadjuvant chemotherapy, CDDP cisplatin, VP-16 etoposide, ND not described